H Andrew Strong

1.3k total citations
18 papers, 722 citations indexed

About

H Andrew Strong is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, H Andrew Strong has authored 18 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Oncology. Recurrent topics in H Andrew Strong's work include Inflammatory mediators and NSAID effects (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). H Andrew Strong is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). H Andrew Strong collaborates with scholars based in Canada, United Kingdom and United States. H Andrew Strong's co-authors include J. Malcolm O. Arnold, Claudio Munoz, David G. Bailey, J. David Spence, C. F. George, Jerrold Lerman, A. G. Renwick, Kenneth M. LeDez, Frederick A. Burrows and A.G. Renwick and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Anesthesiology and Biochemical Pharmacology.

In The Last Decade

H Andrew Strong

17 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Andrew Strong Canada 12 232 176 169 164 133 18 722
Cong Xie China 17 56 0.2× 275 1.6× 50 0.3× 96 0.6× 60 0.5× 48 813
K Hrubý Austria 11 40 0.2× 109 0.6× 31 0.2× 221 1.3× 68 0.5× 71 573
B A Leatherdale United Kingdom 18 29 0.1× 128 0.7× 109 0.6× 38 0.2× 55 0.4× 34 900
Jiaoyue Zhang China 15 58 0.3× 203 1.2× 40 0.2× 18 0.1× 76 0.6× 43 1.1k
Tanaka Japan 7 27 0.1× 123 0.7× 28 0.2× 164 1.0× 27 0.2× 13 472
Emina Čolak Serbia 15 111 0.5× 128 0.7× 58 0.3× 11 0.1× 36 0.3× 45 687
A. McBurney United Kingdom 16 21 0.1× 156 0.9× 11 0.1× 99 0.6× 59 0.4× 38 679
Satoru Mineshita Japan 14 86 0.4× 174 1.0× 4 0.0× 197 1.2× 171 1.3× 61 705
Rema Mohan India 11 90 0.4× 54 0.3× 75 0.4× 10 0.1× 12 0.1× 17 647
William J. Leahey United Kingdom 16 16 0.1× 103 0.6× 37 0.2× 25 0.2× 41 0.3× 35 812

Countries citing papers authored by H Andrew Strong

Since Specialization
Citations

This map shows the geographic impact of H Andrew Strong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Andrew Strong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Andrew Strong more than expected).

Fields of papers citing papers by H Andrew Strong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Andrew Strong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Andrew Strong. The network helps show where H Andrew Strong may publish in the future.

Co-authorship network of co-authors of H Andrew Strong

This figure shows the co-authorship network connecting the top 25 collaborators of H Andrew Strong. A scholar is included among the top collaborators of H Andrew Strong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Andrew Strong. H Andrew Strong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Strong, H Andrew, et al.. (2002). DURATION OF SKIN PHOTOSENSITIVITY AND INCIDENCE OF PHOTOSENSITIVITY REACTIONS AFTER ADMINISTRATION OF VERTEPORFIN. Retina. 22(6). 691–697. 26 indexed citations
3.
Miller, Joan W., Michel Sickenberg, E. S. Gragoudas, et al.. (1996). Selected angiographic findings following photodynamic therapy of subfoveal choroidal neovascularization using BPD. 37(3). 1 indexed citations
4.
Levy, Julia G., et al.. (1996). <title>Clinical status of benzoporphyrin derivative</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2625. 86–95. 10 indexed citations
5.
Bailey, David G., J. Malcolm O. Arnold, H Andrew Strong, Claudio Munoz, & J. David Spence. (1993). Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clinical Pharmacology & Therapeutics. 54(6). 589–594. 154 indexed citations
6.
Bolli, Peter, John Cobby, Satoshi Handa, et al.. (1991). Once- vs. Twice-Daily Nitrendipine in the Treatment of Mild to Moderate Hypertension. Journal of Cardiovascular Pharmacology. 17(Supplement 2). S182–S185.
7.
Burrows, Frederick A., Jerrold Lerman, Kenneth M. LeDez, & H Andrew Strong. (1991). Pharmacokinetics of lidocaïne in children with congenital heart disease. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 38(2). 196–200. 16 indexed citations
8.
Burrows, Frederick A., Jerrold Lerman, Kenneth M. LeDez, & H Andrew Strong. (1990). Alpha1-acid glycoprotein and the binding of lidocaine in children with congenital heart disease. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 37(8). 883–888. 4 indexed citations
9.
Lerman, Jerrold, H Andrew Strong, Kenneth M. LeDez, et al.. (1989). Effects of age on the serum concentration of α1-acid glycoprotein and the binding of lidocaine in pediatric patients. Clinical Pharmacology & Therapeutics. 46(2). 219–225. 77 indexed citations
10.
Lerman, Jerrold, M. E. McLeod, & H Andrew Strong. (1989). Pharmacokinetics of Intravenous Dantrolene in Children. Anesthesiology. 70(4). 625–629. 27 indexed citations
11.
Lerman, Jerrold, et al.. (1988). PHARMACOKINETICS OF INTRAVENOUS DANTROLENE IN MALIGNANT HYPERTHERMIA SUSCEPTIBLE (MHS) PEDIATRIC PATIENTS. Anesthesia & Analgesia. 67(Supplement). 133–133. 2 indexed citations
12.
Strong, H Andrew & Michael Spino. (1987). Highly sensitive determination of cimetidine and its metabolites in serum and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 422. 301–308. 21 indexed citations
13.
Strong, H Andrew, et al.. (1987). The reduction of sulphinpyrazone and sulindac by intestinal bacteria. Xenobiotica. 17(6). 685–696. 56 indexed citations
14.
Strong, H Andrew, et al.. (1986). Effects of Ischaemic Heart Disease, Crohnʼs Disease and Antimicrobial Therapy on the Pharmacokinetics of Sulphinpyrazone. Clinical Pharmacokinetics. 11(5). 402–410. 3 indexed citations
15.
Renwick, A. G., H Andrew Strong, & C. F. George. (1986). The role of the gut flora in the reduction of sulphoxide containing drugs. Biochemical Pharmacology. 35(1). 64–64. 16 indexed citations
16.
Strong, H Andrew, Natalie J. Warner, A. G. Renwick, & C F George. (1985). Sulindac metabolism: The importance of an intact colon. Clinical Pharmacology & Therapeutics. 38(4). 387–393. 46 indexed citations
17.
Strong, H Andrew, et al.. (1984). Role of the gut flora in the reduction of sulfinpyrazone in humans.. Journal of Pharmacology and Experimental Therapeutics. 230(3). 726–732. 24 indexed citations
18.
Strong, H Andrew, A.G. Renwick, & C. F. George. (1984). The site of reduction of sulphinpyrazone in the rabbit. Xenobiotica. 14(10). 815–826. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cong Xie Breakdown of academic impact, for papers by K Hrubý Breakdown of academic impact, for papers by B A Leatherdale Breakdown of academic impact, for papers by Jiaoyue Zhang Breakdown of academic impact, for papers by Tanaka Breakdown of academic impact, for papers by Emina Čolak Breakdown of academic impact, for papers by A. McBurney Breakdown of academic impact, for papers by Satoru Mineshita Breakdown of academic impact, for papers by Rema Mohan Breakdown of academic impact, for papers by William J. Leahey
Rankless by CCL
2026